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Should heroin be prescribed to  
heroin misusers?
tenance treatment, obtained positive results on 
similar outcomes.6 7 Moreover, heroin assisted 
maintenance treatment was found to be cost 
beneficial in Switzerland8 and cost effective in 
the Netherlands compared with methadone 
maintenance treatment.9 Since these results 
were obtained, this treatment option has been 
extended beyond the trial periods, and heroin 
has been approved by the regulatory bodies for 
treating opioid dependence. In all three coun�
tries, the intake of medical heroin is supervised 
and occurs a maximum of three times a day, 
and patients recover from acute intoxication 
before leaving the treatment clinic. Notably, 
heroin has been a treatment option for heroin 
misusers in the United Kingdom for several 
decades, albeit on a relatively small scale and 
under different conditionswith lower aver�
age dosing and less supervised intake.10
Use of maintenance
The above summary makes the recent use of 
heroin assisted maintenance treatment look 
like a straightforward scientific success story, 
and not like a topic for debate in the BMJ. 
However, since the original heroin assisted 
maintenance treatment programme was 
proposed in Switzerland in the early 1990s, 
there has been scientific, and perhaps more 
importantly, larger public debate on the eth�
ics, safety, and clinical value of prescribing 
heroin, and to a lesser degree, on maintenance 
treatment in general. Overall, maintenance 
with buprenorphine and, to a larger degree, 
methadone is more successful than treatment 
focusing on abstinence or using placebos.11 
Given the nature of opioid 
dependence as a chronic 
relapsing disease,12 these 
results are not surprising. 
Opioid maintenance 
treatment generally seems to be well justified 
for treating this disease. And if maintenance is   
generally justifiable as a form of treatment, why 
should heroin not be used as one such phar�     
macological agent?� One reason that has been      
cited is safety, both for the patient13 and for the 
general public (for example, through diversion 
or the risk of trivialising the dangers of heroin, 
leading to an increase in use). Results from 
the Swiss studies, however, show that mortal�
ity among patients in heroin assisted mainte�
nance programmes is low, and lower than for 
patients in other maintenance programmes.14 
In addition, the wider safety concerns could 
not be empirically confirmed in Switzerland 
or the Netherlands.15 Finally, the incidence of 
heroin dependence has decreased greatly in 
Switzerland since the start of the trials, and cur�
rently heroin has a more negative image than 
it did 15 years ago.16
Overall, we see no convincing reason why 
heroin assisted maintenance treatment should 
not be part of a comprehensive treatment sys�
tem for opioid dependence. However, the 
development of an overall integrated treat�
ment system is crucial. All studies to date 
have been conducted in samples of refractory 
addicts with severely compromised health and 
several previous failed attempts of methadone 
maintenance treatment. Our current knowl�
edge about the effectiveness of heroin assisted 
maintenance treatment is restricted to these 
groups and to the context of countries where 
there is already an established and effective 
comprehensive system for treating opioid 
dependence. Although we currently do not 
have the necessary empirical evidence for 
establishing heroin assisted maintenance treat�
ment in other circumstances, addition of her�
oin assisted maintenance treatment would be 
likely to improve the overall treatment system, 
especially with respect to so called treatment 
resistant and refractory opioid addicts.
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Recently, a public hearing of 
a Danish parliament sub�
commi t t ee  d i s cus sed 
whether heroin assisted maintenance treat�
ment should be offered experimentally to 
reduce health and social harm related to use 
of heroin (www.tekno.dk/ordineret�heroin). 
This is just one in a series of similarexisting 
or proposedprogrammes in Europe, North 
America, and Australia.1 We believe that such 
treatment is appropriate for heroin misusers 
under certain circumstances.
Supporting evidence
Increasing heroin misuse in the United States 
in the early 1970s led to a public debate about 
prescribing heroin as a last resort form of 
opioid maintenance therapy for people with 
chronic heroin dependence. In 1973 Lorrin 
Koran advocated in the New England Journal 
of Medicine that “carefully designed clinical 
research on the safety and efficacy of heroin 
maintenance should be undertaken, particu�
larly with addicts not helped in current treat�
ments.”2 Some 35 years later, three important 
research studies have been completed. In Swit�
zerland, a small randomised trial3 and a study 
using natural cohort designs4 found heroin 
assisted maintenance treatment to be feasible 
and effective for a group of  heroin misusers 
who were refractory to treatment, as charac�
terised by long term heroin 
dependence; physical, psy�
chological, or social deficits; 
and unsuccessful previous 
treatment.4 5 Effectiveness 
was observed in treatment retention; somatic 
health outcomes such as epileptic episodes, 
abscesses, or cachexia; mental health out�
comes such as affective or anxiety disorders; 
heroin and cocaine misuse; and criminal out�
comes such as property offences or drug traf�
ficking (on the basis of self report and objective 
measures).5 
Large randomised controlled clinical tri�
als in the Netherlands and Germany, which 
compared different modes of heroin assisted 
maintenance treatment with methadone main�
Mortality among patients in 
heroin assured maintenance 
programmes is low
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Prescribing heroin to heroin 
addicts is a strategy beloved by 
top police officers1 and succes�
sive home secretaries.2 It is a strategy, 
though, borne of utter frustration at our 
seeming inability to tackle an escalating drug 
problem. If you cannot stop addicts commit�
ting crimes to fund their drug habit then, so 
the argument goes, the next best thing is to 
provide them with the drugs that are the rea�
son they are committing the crimes in the 
first place. The logic may seem faultless, but 
at the back of your mind is the nagging 
 question, “Is it treatment or is it social prob�
lem prescribing?�”
The evidence in relation to heroin pre�
scribing is far from conclusive. On the posi�
tive side Nordt and Stohler have suggested 
that heroin prescribing led to a large reduc�
tion in incidence of heroin addiction in 
Switzerland, although the authors also point 
out that such prescribing may have reduced 
individuals’ inclinations to cease their her�
oin use.3 A London study found no health 
benefits associated with heroin prescribing,4 
whereas various Dutch and Swiss heroin 
trials have identified a range of benefits 
including improved social functioning and 
psychological and physical health.5 6 What 
addicts with a prescription for the drug that 
they have become dependent on. And yet 
the reason they are committing those crimes, 
and taking such enormous and persistent 
risks with their health, is because the drugs 
have become more important than life 
itselfthat is the nature of drug addiction. 
And that is the problem that drug treatment 
services need to tackle. 
Research has shown that with the right 
services in place it is possible to do more 
than simply stabilise addicts’ continued 
drug use through the 
prescribing route. For 
example, the Australian 
treatment outcome study, 
which followed up 429 
heroin users recruited 
from a random sample of drug treatment 
 agencies 36 months after starting treatment, 
found that 40% of drug users had been 
abstinent for the preceding 12 months and 
25% had been abstinent for the preceding 
24 months.10 In a similar Scottish study of 
695 addicts, re�interviewed 33 months after 
they had started treatment for drug misuse, 
29.4% of those who had been provided 
with residential rehabilitation had been 
abstinent for at least 90 days before being 
interviewed compared with only 3.4% of 
those receiving methadone maintenance.11 
All of the residential rehabilitation services 
included in this study followed an absti�
nence based programme.
But do addicts coming forward for treat�
ment actually want heroin to be prescribed 
to them?� A study of over 1033 drug users 
starting treatment in 2001 asked participants 
what they wanted to get from the drug treat�
ment services they were contacting.12 Most 
of those questioned said that they wanted 
the services to help them become drug free. 
Health services need to ensure that they are 
supporting addicts’ attempts to become drug 
free, and they need to be extremely cautious 
about any extension of a policy that could 
be seen as a route to maintaining rather than 
reducing an individual’s drug dependency.
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Some heroin addicts are very difficult to treat. Jürgen Rehm and Benedikt Fischer believe that 
maintenance with heroin is the way forward for this group, but Neil McKeganey argues that it is 
treating the effects of misuse not the addiction
is often quite difficult to identify from these 
studies is the degree to which the improved 
outcomes are the result of the heroin pre�
scribed or other elements of the therapeutic 
programme provided. The cost of treating 
an addict with heroin is estimated to be three 
to four times that of treating an addict with 
methadone.7
Risks of prescribing
In the face of the additional costs and incon�
clusive evidence, many clinicians are wary of 
prescribing heroin. Their 
anxieties are understand�
able, given the high profile 
cases of doctors who have 
prescribed heroin to addicts 
and then subsequently found 
themselves facing a General Medical Council 
inquiry into their prescribing practices.8
At a clinical level prescribing heroin to her�
oin addicts is a risky strategy. Once you start, 
it is difficult not to feel that you have ceded 
authority for your prescribing to your patient. 
What, for example, do you say to patients who 
threaten to resume their previous life of crime 
if you reduce their heroin prescription?� What 
do you say to the cocaine addict who asks why 
he cannot have cocaine provided in the same 
way as the heroin addict?� Opening up heroin 
prescribing to addicts could lead to massive 
pressure on doctors to prescribe increasing 
amounts of the drug. 
It was in part as a result of that pressure that 
the Interdepartmental Committee on Drug 
Addiction advised the UK government in 
1965 that only appropriately certified doctors 
should prescribe heroin to addicts. The com�
mittee’s decision was influenced by the case 
of Lady Frankau, a noted London psychiatrist 
who in 1962 prescribed more than 600 000 
heroin tablets to her addict patients.9
What are we treating?
Prescribing heroin to heroin addicts, how�
ever, makes sense only if your primary con�
cern is to treat not their drug dependency 
but the consequences of their drug use. You 
may want to reduce their use of street drugs, 
the risks to health from HIV or hepatitis C 
virus, the risks of overdose, or their crimi�
nality. With all of these aims in mind you 
may conclude that it makes sense to provide 
I
at the back of your mind is 
the nagging question, “Is 
it treatment or is it social 
problem prescribing?”
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